Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
Identifying environmental antigens that activate myelin-specific T cells.
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
The Ins and Outs of B Cells in Multiple Sclerosis.
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Applying the RE-AIM Framework to Inform the Development of a Multiple Sclerosis Falls-Prevention Intervention.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Examination of the Chicago Multiscale Depression Inventory and Initial Validation of a Positive Scale.
Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
New Developments in Murine Imaging for Assessing Photoreceptor Degeneration In Vivo.
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Immunology for understanding the pathogenesis of multiple sclerosis.
Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation.
Pages
« first
‹ previous
…
654
655
656
657
658
659
660
661
662
…
next ›
last »